Reckitt Benckiser Gp

Statement regarding Mead Johnson

RNS Number : 8437V
Reckitt Benckiser Group PLC
02 February 2017






2 February 2017




Reckitt Benckiser Group plc
Statement regarding Mead Johnson

Reckitt Benckiser Group plc ("RB") notes the recent press speculation regarding a possible transaction involving Mead Johnson Nutrition Company ("Mead Johnson").


RB confirms that it is in advanced negotiations to acquire each Mead Johnson share for $90 in cash, valuing Mead Johnson's entire share capital at approximately $16.7 billion.


The parties are presently engaged in a period of due diligence and contract discussion.


RB presently expects to finance the possible transaction through a combination of cash and debt, whilst retaining a strong investment grade credit rating.


There is no certainty that any transaction will ultimately be agreed, nor as to the terms on which any transaction might occur.


A further announcement will be made as appropriate.


For further information, please contact:


Richard Joyce

SVP, Investor Relations, Communications & External Affairs



+44 (0)1753 217800

Brunswick (Financial PR)

Gabrielle Silver & David Litterick


              +44 (0)20 7404 5959



This information is provided by RNS
The company news service from the London Stock Exchange